Pharmaceutical Technology lists ten of the most popular tweets on cardiovascular in February 2020, based on data from GlobalData’s Influencer Platform. The top tweets were chosen from influencers as tracked by GlobalData’s Influencer Platform, which is based on a scientific process that works on pre-defined parameters. Influencers are selected after a deep analysis of the influencer’s relevance, network strength, engagement, and leading discussions on new and emerging trends.

Top tweets on cardiovascular in February 2020

1. Eric Topol’s tweet on FDA’s approval of the cardiovascular AI-based software for echocardiograms

Eric Topol, an American cardiologist and scientist, shared an article on the AI-guided imaging acquiring system that can help doctors and medical professionals in taking ultrasound images of the heart, also known as echocardiograms. The technology is developed by San Francisco-based healthcare solutions provider Caption Health. This diagnostic system is expected to meet the shortage of expertise in many hospitals.

Username: Eric Topol

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Twitter handle: @EricTopol

Retweets: 96

Likes: 160

2. Gregg Stone’s tweet on very late stent-related MACE

Gregg Stone, an interventional cardiologist, shared an article on 19 stent randomised controlled trials for detecting the prevalence of stent-related adverse events that occurred after percutaneous coronary intervention (PCI). Though major adverse cardiovascular events (MACE) are believed to occur during the first year after PCI, very late or long-term events were not established.

The analysis revealed that very late stent-related events occurred between one and five years, at the rate of 2% every year with all kinds of stents and with no plateau evident.

Username: Gregg W. Stone

Twitter handle: @GreggWStone

Retweets: 79

Likes: 223

3. Dr Martha Gulati’s tweet on heart health awareness

Dr Martha Gulati, division chief of cardiology for the UA College of Medicine, Phoenix, tweeted on heart health awareness. She states that most women are unaware of the hidden risks associated with heart disease. As a result, regular trials and awareness is important for women.

Username: Dr. Martha Gulati

Twitter handle: @DrMarthaGulati

Retweets: 62

Likes: 122

4. Michael Gibson’s tweet on the launch of first-of-its-kind virtual study to improve heart health

Michael Gibson, an interventional cardiologist, researcher and educator, shared an article on the launch of Heartline, a virtual clinical study initiated by Johnson & Johnson and Apple. The collaboration aims to understand whether certain health features in new iPhones and Apple devices can help improve outcomes and reduce the risks of strokes and deaths.

Username: C. Michael Gibson

Twitter handle: @CMichaelGibson

Retweets: 55

Likes: 188

5. Chris P Gale’s tweet on discontinuing statins for primary cardiovascular prevention at the age of 75 years

Chris P Gale, a consultant cardiologist and professor of cardiovascular medicine, shared an article that found that the discontinuation of Statin, led to a 33% increased risk of hospitalisation for cardiovascular events in 75-year-old primary prevention patients. The French study further stated that additional randomised studies were required to confirm the findings and understand the use of statins for primary prevention in the elderly.

Username: Prof Chris P Gale

Twitter handle: @cpgale3

Retweets: 54

Likes: 107

6. John P Erwin’s tweet on push-up capacity and subsequent CVD event incidence

John P Erwin, a cardiologist and professor, shared an article on the association between push-up capacities and the lower incidence of cardiovascular disease (CVD). The cohort study on young active men found that 40 or more push-ups were associated with lesser incidence of CVD compared to those able to complete less than 10 push-ups.

Evidence suggests a definite association between increased physical fitness and better heart health and longevity. However, low-cost measures have not been thoroughly studied to evaluate functional capacity and cardiovascular risks, the article stated.

Username: John P Erwin III MD

Twitter handle: @HeartOTXHeartMD

Retweets: 44

Likes: 130

7. Sek Kathiresan’s tweet on FDA’s approval of Bempedoic acid

Sek Kathiresan, a physician-geneticist, re-tweeted on the US Food and Drug Administration’s approval of the new lipid-lowering drug, Bempedoic acid. It is first oral, non-statin, LDL-lowering drug that has been approved since 2002. The Bempedoic acid trials conducted on 3,600 patients found that the drug lowers LDL-C by 15.1% in 12 weeks. The drug was also found to lower total cholesterol, reduce major adverse cardiovascular events.

The influencer added that now the world had more options for LDL lowering, including Statin, Ezetimibe, PCSK9i, and Bempedoic acid, with Inclisiran still in the approval stage.

Username: Sek Kathiresan

Twitter handle: @kathire

Retweets: 40

Likes: 110

8. Dr Deepak Bhatt’s tweet on the degree of benefit of icosapent ethyl in the US

Dr Deepak Bhatt, a cardiologist, shared an article on the results from 3146 patients randomised in the US. The REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl – Intervention Trial) analysis was conducted to understand the benefit of icosapent ethyl in the US. It had been earlier perceived that patients in the US derived lesser benefit that those enrolled outside.

Results of the randomised patients found that the non-US subgroup revealed significant risk reductions from cardiovascular death, nonfatal myocardial infarction, or hospitalisation for unstable angina, while the US subgroup revealed robust reductions across individual as well composite endpoints, including the total number of deaths caused by a heart disease.

Username: Dr. Deepak L. Bhatt

Twitter handle: @DLBHATTMD

Retweets: 38

Likes: 130

9. Wayne’s tweet on America having better healthcare systems and cures today

Wayne, a cardiologist, tweeted on America being much healthier today than it was 20 or 30 years ago. The influencer noted that this could be attributed to better healthcare systems, treatments, and cures. However, a video shared by him points at the Affordable Act Care Act of 2010 to take away incentivisations, and forcing more Americans to succumb to preventable diseases.

Username: Wayne

Twitter handle: @Toaster_Pastry

Retweets: 35

Likes: 263

10. Harlan Krumholz’s tweet on the comparative effectiveness of Chlorthalidone versus Hydrochlorothiazide

Harlan Krumholz, a cardiologist and healthcare researcher, shared an article on the relative effectiveness, as well as the safety of Chlorthalidone and Hydrochlorothiazide. A cohort study of 730,255 individuals, found no difference in the effectiveness of both the drugs. However, Hydrochlorothiazide was found to be safer.

The study also found that Chlorthalidone was associated with no significant cardiovascular benefits when compared with hydrochlorothiazide. In fact, its use revealed greater outcomes associated with renal and electrolyte deviations.

Username: Harlan Krumholz

Twitter handle: @hmkyale

Retweets: 35

Likes: 82